Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer
Temporomandibular Joint Disorder
University of Maryland, Baltimoremonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Temporomandibular Joint Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Granisetron Karolinska Institutet | Phase 4 | BB |
Trazodone Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 | BB |
Noramitriptyline Duke University | Phase 2 | B |
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE University of Maryland, Baltimore | Phase 1/2 | CCC |
Capsaicin Istanbul University | N/A | D |
Diclofenac Istanbul University | N/A | D |
Ethylicum University of Florida | N/A | D |
Same molecule, other indications
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →